Daniel Checketts
Daniel Checketts publishes mostly in Pharmacology, Psychiatry and Mental health and Molecular Biology, on topics such as Cannabis and Cannabinoid Research, Epilepsy research and treatment and Drug Transport and Resistance Mechanisms.
- World rank
- #487,164 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #42,463 of 367,258
- Works
- 37
- Citations
- 2.9k
- Citations per work
- 79.2
What does Daniel Checketts research?
Daniel Checketts's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2566.6%
- Medicine2566.6%
- Everything else1026.5%
- Life Sciences36.9%
- 1Pharmacology28% of their works
- 2Psychiatry and Mental health24% of their works
- 3Molecular Biology7% of their works
- 4Genetics5% of their works
- 5Neurology5% of their works
- 6Oncology5% of their works
Research topics
Which keywords describe Daniel Checketts's research?
The keywords of their largest research topics: Neurological Disorders, Metabolic Disorders, Cannabinoid Receptors, Endocannabinoid System, Epilepsy, Classification, Seizures and Cognitive Impairment.
- Newborn Screening
- Multiple Sclerosis
- Biochemical Genetics
- Sickle-cell Disease
- Botulinum Toxin
- ATP-dependent Transporters
- Cognitive Impairment
- Classification
- Endocannabinoid System
- Metabolic Disorders
- Neurological Disorders
- Cannabinoid Receptors
- Epilepsy
- Seizures
- Diagnostic Criteria
- Multidrug Resistance
- Neurotoxins
- Thalassemia
- Lymphangioleiomyomatosis
- Neuromyelitis Optica
- Tuberous Sclerosis Complex
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Neurological Disorders332 topics
- Metabolic Disorders322 topics
- Cannabinoid Receptors291 topic
- Endocannabinoid System291 topic
- Epilepsy252 topics
- Classification221 topic
- Seizures221 topic
- Cognitive Impairment62 topics
- Diagnostic Criteria62 topics
- ATP-dependent Transporters51 topic
- Multidrug Resistance51 topic
- Botulinum Toxin41 topic
- Neurotoxins41 topic
- Sickle-cell Disease41 topic
- Thalassemia41 topic
- Biochemical Genetics31 topic
- Lymphangioleiomyomatosis31 topic
- Multiple Sclerosis31 topic
- Neuromyelitis Optica31 topic
- Newborn Screening31 topic
- Tuberous Sclerosis Complex31 topic
Where does Daniel Checketts work?
Daniel Checketts's main affiliation in the publication record is GW Pharmaceuticals (United Kingdom), United Kingdom.
How many publications and citations does Daniel Checketts have?
OpenAlex counts 37 works and 2,929 citations for Daniel Checketts, an h-index of 18, ranking #487,164 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel Checketts. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.